Paper·2026·Commentary
Paper·2017·Research article
Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers
Khemakhem AM, Frye RE, El-Ansary A, Al-Ayadhi L, Bacha AB
Metabolic Brain Disease, 2017
A plain-language summary is not written yet
The foundation is writing summaries of its papers, starting with the most important ones. Until then, the citation and the link to the journal are below.
Citation
Khemakhem, A.M., Frye, R.E., El-Ansary, A. et al. Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers. Metab Brain Dis 32, 1983–1997 (2017). https://doi.org/10.1007/s11011-017-0085-2
More on biomarkers
Paper·2025·Clinical trial
Mitochondrial Supplement Improves Function and Mitochondrial Activity in Autism: A Double-Blind Placebo-Controlled Cross-Over Trial
Paper·2025·Research article
De Novo Variants Predominate in Autism Spectrum Disorder
Paper·2024·Systematic review